{
Thermo Fisher Scientific Inc.

Companies

}
global clinical biomarkers market projected to reach 47 billion by 2031
The global clinical biomarkers market, valued at $25.02 billion in 2023, is projected to reach $47.25 billion by 2031, growing at a CAGR of 8.54%. This growth is driven by rising cancer cases and advancements in diagnostic technologies, despite challenges like high costs and reimbursement issues. Key players include Roche, Abbott, and Johnson & Johnson, with significant developments in biomarker testing for various diseases.
openPR.com
Eurofins Scientific S.E. A PerkinElmer Inc Johnson & Johnson Services Inc. Bio-Rad Laboratories, Inc. Qiagen N.V. Merck KGaA Thermo Fisher Scientific Inc. General Electric Co Siemens Healthineers AG Agilent Technologies, Inc. F. Hoffmann-La Roche Ltd. USA Show more
Healthcare, Market Report
08:45 16.12.2024
global growth trends in the crispr and cas gene market to 2033
The global CRISPR and Cas gene market reached approximately $3.3 billion in 2023, growing at a CAGR of 20.38% since 2018. It is projected to expand to $8.8 billion by 2028 and $24.6 billion by 2033, driven by advancements in cancer therapeutics and gene therapy research. North America leads the market, accounting for 45.3% of the total value in 2023.
GlobeNewswire News Room
United States Dollar Bayer AG Bio-Rad Laboratories, Inc. Pluristem Therapeutics Inc. Genscript Biotech Corporation AstraZeneca PLC Qiagen N.V. Hologic, Inc. Cellectis S.A. Takara Bio Inc. Vertex Pharmaceuticals Inc Thermo Fisher Scientific Inc. Sigma-Aldrich Co. LLC Regeneron Pharmaceuticals Inc Editas Medicine Inc IND GBR ESP CAN AUS ITA IDN JPN BRA DEU FRA RUS KOR CHN USA Show more
Technology & Innovation, Market Report
15:27 13.12.2024
disaster and emergency medicine market poised for significant growth and innovation
The Disaster and Emergency Medicine Market is set for significant growth, driven by technological advancements and strategic collaborations among key players. Comprehensive research, including primary interviews and secondary literature reviews, has validated insights into the current market landscape. Prominent companies like Baxter International, Halyard Health, and 3M Healthcare are pivotal in shaping trends and enhancing emergency response capabilities.
openPR.com
Smith & Nephew plc Thermo Fisher Scientific Inc. B. Braun Melsungen AG Baxter International Inc. USA John Edward Jones Show more
Healthcare, Market Report
09:41 09.12.2024
Growth Factors Market Insights Opportunities and Challenges in Emerging Industries
The Growth Factors Market is influenced by strategic mergers, consumer shifts towards sustainability, and advancements in data analytics. Key challenges include cybersecurity risks and skilled labor shortages, while opportunities lie in personalized e-commerce and renewable energy solutions. Major players like Johnson & Johnson and Thermo Fisher Scientific are shaping the competitive landscape through innovation and market expansion.
GlobeNewswire News Room
Lonza Group AG Sartorius AG Merck & Co., Inc. Thermo Fisher Scientific Inc. Johnson & Johnson Services Inc. F. Hoffmann-La Roche SA Show more
Technology & Innovation, Market Report
14:46 06.12.2024
Nanotechnology in Medicine and Healthcare Market Forecast and Growth Opportunities 2024 to 2031
The Nanotechnology in Medicine and Healthcare Market report provides a comprehensive analysis of market trends, growth opportunities, and competitive dynamics from 2024 to 2031. It covers key segments, including nanoparticles and drug delivery applications, while offering insights into major players like Abbott Laboratories and Johnson & Johnson. The report also includes a SWOT analysis and highlights regional consumption patterns, aiding stakeholders in strategic decision-making.
openPR.com
Merck & Co., Inc. Abbott Laboratories Johnson & Johnson Thermo Fisher Scientific Inc. ZAF EGY ARE NGA SAU Eddy Merckx Brian Johnson Show more
Technology & Innovation, Market Report
11:05 06.12.2024
Top Health Care Stocks to Consider for Investment in 2025
Amgen's MariTide obesity drug showed mid-stage trial results in line with competitors, while Stryker's Mako robotic product and outpatient focus position it as a strong investment. Pfizer's potential divestment of its hospital drugs business could enhance its core growth, and Boston Scientific's promising pipeline supports its long-term outlook. CFRA maintains "buy" ratings for these companies, with specific price targets reflecting their growth potential.
money.usnews.com
Johnson & Johnson Gilead Sciences Inc Boston Scientific Corp Amgen Inc. Stryker Corp Bristol-Myers Squibb Co Merck & Co., Inc. Eli Lilly & Co Thermo Fisher Scientific Inc. Pfizer Inc. USA Sel Hardy Robert F. Kennedy Jr. Paige Meyers Show more
Finance & Economy, Market Report
20:06 29.11.2024
immunoassay market poised for significant growth driven by technological advancements
The global immunoassay market is projected to reach USD 48.8 billion by 2032, driven by rising disease prevalence, technological advancements, and increasing demand for rapid testing solutions. Key growth areas include personalized medicine, oncology, and point-of-care testing, particularly in emerging markets. Major players in the U.S. and Asia-Pacific are leading the charge, supported by robust healthcare investments and innovations in diagnostic capabilities.
PharmiWeb.com
United States Dollar Thermo Fisher Scientific Inc. Abbott Laboratories USA IND CHN DEU JPN GBR Show more
Technology & Innovation, Market Report
17:22 27.11.2024
poultry healthcare market projected to reach 12.55 billion by 2028
The poultry healthcare market is projected to grow from $7.67 billion in 2023 to $12.55 billion by 2028, driven by rising disease outbreaks and increasing global poultry consumption. Key trends include technological integration, biosecurity measures, and customized nutrition programs, with North America leading the market in 2023. Major players include Zoetis Inc., Merck & Co Inc., and Boehringer Ingelheim.
openPR.com
Samsung Electronics Thermo Fisher Scientific Inc.
Healthcare, Market Report
06:56 27.11.2024
global metagenomic sequencing market poised for significant growth by 2030
The Global Metagenomic Sequencing Market is projected to grow from US$ 1.41 billion in 2023 to US$ 4.39 billion by 2030, with a CAGR of 17.6%. Key factors driving this growth include increased demand, technological advancements, and a broadening customer base, alongside insights into competitive dynamics and market segmentation. Major players include Illumina, QIAGEN, and Thermo Fisher Scientific, with applications spanning drug discovery, disease diagnosis, and environmental remediation.
openPR.com
United States Dollar BGI Group GENEWIZ Novogene Corporation Eurofins Scientific SE PerkinElmer Macrogen Zymo Research Nugen Technologies Inc. Takara Bio Inc. Swift Biosciences Thermo Fisher Scientific Inc. BaseClear MR DNA (Molecular Research) Diversigen CosmosID Oxford Nanopore Technologies NEW England Biolabs Inc. Illumina, Inc. Qiagen N.V. Microsynth AG Priya Pandey Viju Shah Show more
Healthcare, Market Report
11:59 26.11.2024
hi-tech medical devices market poised for growth driven by innovation and sustainability
The global Hi-Tech Medical Devices Market is experiencing significant growth driven by technological advancements, changing consumer preferences, and a focus on sustainability. Key objectives include forecasting market size across regions, analyzing growth factors, and identifying opportunities for stakeholders. Major players in the market include Medtronic, Abbott Laboratories, and Johnson & Johnson, with a comprehensive analysis of competitive dynamics and market trends provided in the research report.
openPR.com
Medtronic Johnson & Johnson Philips Healthcare Siemens Healthineers AG Baxter International Inc. Abbott Laboratories Edwards Lifesciences Corporation Hologic, Inc. DexCom, Inc. Fresenius Medical Care AG Thermo Fisher Scientific Inc. Becton, Dickinson and Company Varian Medical Systems Boston Scientific Corporation Zimmer Biomet Holdings, Inc. Intuitive Surgical, Inc. Illumina, Inc. St. Jude Medical, Atrial Fibrillation Division Inc. Stryker Corporation GE HealthCare Technologies Inc. USA DEU ITA MEX ARG AUS ZAF IND SAU RUS JPN KOR BRA CAN ARE ESP CHN Brian Johnson Jeff Stryker Show more
Technology & Innovation, Market Report
05:10 26.11.2024
Trending
Subcategory:
Cryptocurrency Markets Stock Market Updates Cryptocurrency Trends Market Sentiment Analysis Banking Regulations Central Bank Actions Corporate Responsibility & ESG Decentralized Finance (DeFi) Innovations Tokenomics and Crypto Economics Cryptocurrency & Blockchain Regulations Mergers & Acquisitions Cryptocurrency Developments Blockchain Technology Adoption Anti-Money Laundering (AML) Regulations Market Analysis and Predictions Cryptocurrency Regulations Emerging Startups SEC & Financial Compliance Inflation Rates & CPI Data Banking & Investment Regulations
Countries:
USA CHE GBR DEU ARE HKG AUS JPN IND CHN CAN SGP DNK AUT LIE KOR NGA FIN COL VGB
Companies:
Credit Suisse Real Estate Fund Siat Coinbase Global, Inc. BlackRock, Inc. Solana USD Ripples USD Ethereum USD Apple Inc. Tesla, Inc. Fidelity Contrafund Cardano USD NVIDIA Corporation Grayscale Litecoin Trust Chainlink USD Tether USDt CNY Google Inc. Amazon.com, Inc. MicroStrategy Inc Franklin Templeton - Franklin M End Federal Reserve USD MicroStrategy Incorporated
Currencies:
United States Dollar Euro Swiss Franc Japanese Yen Australian Dollar Indian Rupee Canadian Dollar Mozambican Metical British Pound Sterling Norwegian Krone Mongolian Tögrög Colombian Peso Singapore Dollar
People:
Donald Trump Ali Martinez Elon Musk Karin Keller-Sutter Jerome Powell Ueli Maurer Michael J. Saylor Gary Gensler Thomas Jordan Colm Kelleher Alan Santana Paul Atkins Joe Rogan Martin Schlegel Isabelle Chassot Mario Nawfal Paolo Ardoino Sergio Ermotti Dana White Joe Biden

MachinaCore is a highly modular and scalable system that allows users to build custom widgets and tools tailored to their specific financial data needs, while seamlessly integrating with other MachinaLabs products, like Machinary, MachinaAI Modules and MachinaTrader.

Links

Address

Waitlist

We’re granting exclusive early access to the first 500 users from december 20.

© 2024 by Machinary.com - Version: 1.0.0.0. All rights reserved

Layout

Color mode

Theme mode

Layout settings

Save settings
Seems like the connection with the server has been lost. It can be due to poor or broken network. Please hang on while we're trying to reconnect...
Oh snap! Failed to reconnect with the server. This is typically caused by a longer network outage, or if the server has been taken down. You can try to reconnect, but if that does not work, you need to reload the page.
Oh man! The server rejected the attempt to reconnect. The only option now is to reload the page, but be prepared that it won't work, since this is typically caused by a failure on the server.